The Company is comprised of two operating groups. The Acacia Technologies group develops, acquires, and licenses patented technologies. The CombiMatrix group is seeking to become a diversified biotechnology business.


Updates from The Motley Fool

Latest updates on CombiMatrix from Fool.com.
The Fool Looks Ahead

It's going to be an eventful week if you know where to look.

CombiMatrix Names New CEO

The DNA testing firm appoints Marck McDonough to the top executive position.



Stock Performance

View Interactive CBMX Charts
Sponsored by

Key Data Points

Primary metrics and data points about CombiMatrix.
Current Price: $4.80
Prev Close: $4.70
Open: $4.70
Bid: $4.10
Ask: $5.50
Day's Range: $4.70 - $4.90
52wk Range: $2.15 - $5.85
Volume: 37,542
Avg Vol 113,728
Market Cap: $14M
P/E (ttm): -1.44
EPS (ttm): ($3.27)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about CombiMatrix.
CAPS Rating 0 out of 5
 
3 Outperform
1 Underperform
CAPS All Stars
 
0 Outperform
0 Underperform

How do you think CombiMatrix will perform against the market?



You pick for CombiMatrix is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark McDonough, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for CombiMatrix.

The Company is comprised of two operating groups. The Acacia Technologies group develops, acquires, and licenses patented technologies. The CombiMatrix group is seeking to become a diversified biotechnology business.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT